These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11165455)

  • 1. Physician-patient discussions of controversial cancer screening tests.
    Dunn AS; Shridharani KV; Lou W; Bernstein J; Horowitz CR
    Am J Prev Med; 2001 Feb; 20(2):130-4. PubMed ID: 11165455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.
    Linder SK; Hawley ST; Cooper CP; Scholl LE; Jibaja-Weiss M; Volk RJ
    BMC Fam Pract; 2009 Mar; 10():19. PubMed ID: 19296843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care physicians' use of an informed decision-making process for prostate cancer screening.
    Volk RJ; Linder SK; Kallen MA; Galliher JM; Spano MS; Mullen PD; Spann SJ
    Ann Fam Med; 2013; 11(1):67-74. PubMed ID: 23319508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.
    Guerra CE; Jacobs SE; Holmes JH; Shea JA
    J Gen Intern Med; 2007 Jul; 22(7):901-7. PubMed ID: 17549576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US men discussing prostate-specific antigen tests with a physician.
    McFall SL
    Ann Fam Med; 2006; 4(5):433-6. PubMed ID: 17003144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.
    Wilkes MS; Day FC; Srinivasan M; Griffin E; Tancredi DJ; Rainwater JA; Kravitz RL; Bell DS; Hoffman JR
    Ann Fam Med; 2013; 11(4):324-34. PubMed ID: 23835818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Online Information-Seeking and Adherence to Guidelines for Breast and Prostate Cancer Screening.
    Kim H; Filson C; Joski P; von Esenwein S; Lipscomb J
    Prev Chronic Dis; 2018 Apr; 15():E45. PubMed ID: 29679480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
    Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
    J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Gigerenzer G; Mata J; Frank R
    J Natl Cancer Inst; 2009 Sep; 101(17):1216-20. PubMed ID: 19671770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.
    Feng B; Srinivasan M; Hoffman JR; Rainwater JA; Griffin E; Dragojevic M; Day FC; Wilkes MS
    Ann Fam Med; 2013; 11(4):315-23. PubMed ID: 23835817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussions about prostate cancer screening between U.S. primary care physicians and their patients.
    Hall IJ; Taylor YJ; Ross LE; Richardson LC; Richards TB; Rim SH
    J Gen Intern Med; 2011 Oct; 26(10):1098-104. PubMed ID: 21416405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African american primary care physicians' prostate cancer screening practices.
    Ross LE; Hall IJ
    J Prim Care Community Health; 2014 Jan; 5(1):36-43. PubMed ID: 24327595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of physician-patient discussions on the likelihood of prostate-specific antigen testing.
    Ross LE; Richardson LC; Berkowitz Z
    J Natl Med Assoc; 2006 Nov; 98(11):1823-9. PubMed ID: 17128693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient recall program to enhance decisions about prostate cancer screening: a feasibility study.
    Denberg TD; Bhide M; Soenksen A; Mizrahi T; Shields L; Lin CT
    BMC Fam Pract; 2009 Nov; 10():75. PubMed ID: 19948028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
    Kushalnagar P; Hill C; Carrizales S; Sadler GR
    J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.
    Austin OJ; Valente S; Hasse LA; Kues JR
    Arch Fam Med; 1997; 6(5):453-8. PubMed ID: 9305688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.